These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31152133)

  • 1. Intracellular iron deficiency in pulmonary arterial smooth muscle cells induces pulmonary arterial hypertension in mice.
    Lakhal-Littleton S; Crosby A; Frise MC; Mohammad G; Carr CA; Loick PAM; Robbins PA
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13122-13130. PubMed ID: 31152133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1 induces lysyl oxidase expression in pulmonary artery smooth muscle cells.
    Maruyama H; Sakai S; Dewachter L; Dewachter C; Rondelet B; Naeije R; Ieda M
    Can J Physiol Pharmacol; 2020 Sep; 98(9):629-636. PubMed ID: 32615041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
    Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y
    Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia induces pulmonary artery smooth muscle dysfunction through mitochondrial fragmentation-mediated endoplasmic reticulum stress.
    Zhuan B; Wang X; Wang MD; Li ZC; Yuan Q; Xie J; Yang Z
    Aging (Albany NY); 2020 Nov; 12(23):23684-23697. PubMed ID: 33221740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-18a-5p contributes to enhanced proliferation and migration of PASMCs via targeting Notch2 in pulmonary arterial hypertension.
    Miao R; Liu W; Qi C; Song Y; Zhang Y; Fu Y; Liu W; Lang Y; Zhang Y; Zhang Z
    Life Sci; 2020 Sep; 257():117919. PubMed ID: 32585247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
    Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hepcidin/Ferroportin axis modulates proliferation of pulmonary artery smooth muscle cells.
    Ramakrishnan L; Pedersen SL; Toe QK; West LE; Mumby S; Casbolt H; Issitt T; Garfield B; Lawrie A; Wort SJ; Quinlan GJ
    Sci Rep; 2018 Aug; 8(1):12972. PubMed ID: 30154413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 mediates hypoxia-induced inhibition of voltage-gated K+ channel expression in pulmonary arterial myocytes.
    Whitman EM; Pisarcik S; Luke T; Fallon M; Wang J; Sylvester JT; Semenza GL; Shimoda LA
    Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L309-18. PubMed ID: 18065659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling.
    Wang J; Tian XT; Peng Z; Li WQ; Cao YY; Li Y; Li XH
    Vascul Pharmacol; 2019 Jun; 117():35-44. PubMed ID: 30610955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension.
    Abid S; Marcos E; Parpaleix A; Amsellem V; Breau M; Houssaini A; Vienney N; Lefevre M; Derumeaux G; Evans S; Hubeau C; Delcroix M; Quarck R; Adnot S; Lipskaia L
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31320454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin S promotes the development of pulmonary arterial hypertension.
    Chang CJ; Hsu HC; Ho WJ; Chang GJ; Pang JS; Chen WJ; Huang CC; Lai YJ
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L1-L13. PubMed ID: 31017016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling.
    Zhang S; Wang J; Qi X; Tao X; Xie W; Wan J; Shen YH; Zhai Z
    Exp Cell Res; 2021 Jan; 398(1):112392. PubMed ID: 33227315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA‑15a‑5p induces pulmonary artery smooth muscle cell apoptosis in a pulmonary arterial hypertension model via the VEGF/p38/MMP‑2 signaling pathway.
    Zhang W; Li Y; Xi X; Zhu G; Wang S; Liu Y; Song M
    Int J Mol Med; 2020 Feb; 45(2):461-474. PubMed ID: 31894295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.
    Kurosawa R; Satoh K; Kikuchi N; Kikuchi H; Saigusa D; Al-Mamun ME; Siddique MAH; Omura J; Satoh T; Sunamura S; Nogi M; Numano K; Miyata S; Uruno A; Kano K; Matsumoto Y; Doi T; Aoki J; Oshima Y; Yamamoto M; Shimokawa H
    Circ Res; 2019 Jul; 125(3):309-327. PubMed ID: 31195886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cellular iron deficiency in controlling iron export.
    Link C; Knopf JD; Marques O; Lemberg MK; Muckenthaler MU
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129829. PubMed ID: 33340587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Macrophage Polarization Induces Experimental Pulmonary Hypertension and Is Observed in Patients With Pulmonary Arterial Hypertension.
    Zawia A; Arnold ND; West L; Pickworth JA; Turton H; Iremonger J; Braithwaite AT; Cañedo J; Johnston SA; Thompson AAR; Miller G; Lawrie A
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):430-445. PubMed ID: 33147993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonists to endothelin receptor type B promote apoptosis in human pulmonary arterial smooth muscle cells.
    Sakai S; Maruyama H; Kimura T; Tajiri K; Honda J; Homma S; Aonuma K; Miyauchi T
    Life Sci; 2016 Aug; 159():116-120. PubMed ID: 27021787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
    Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W
    Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.